We are live on ! Find out more
Aviva

Aviva Portfolio holdings

AUM $59.6B
1-Year Est. Return 28.44%
This Fund
S&P 500
This Quarter Est. Return
+11.09%
1 Year Est. Return
+28.44%
3 Year Est. Return
+95.57%
5 Year Est. Return
+123.24%
10 Year Est. Return
+442.53%
AUM
$23.9B
AUM Growth
+$1.43B
Cap. Flow
-$1.37B
Cap. Flow %
-5.75%
Top 10 Hldgs %
23.75%
Holding
1,048
New
64
Increased
472
Reduced
416
Closed
27

Top Buys

Rank Stock Value
1
AMT icon
American Tower
AMT
+$114M
2
MA icon
Mastercard
MA
+$36.5M
3
IQV icon
IQVIA
IQV
+$24.7M
4
JD icon
JD.com
JD
+$21.2M
5
SE icon
Sea Limited
SE
+$19M

Top Sells

Rank Stock Value
1
STLA icon
Stellantis
STLA
+$148M
2
LIN icon
Linde
LIN
+$94.3M
3
QGEN icon
Qiagen
QGEN
+$65.9M
4
AAPL icon
Apple
AAPL
+$53.3M
5
BRK.A icon
Berkshire Hathaway Class A
BRK.A
+$51.8M

Sector Composition

Rank Sector Weight
1 Technology 23.17%
2 Financials 13.47%
3 Healthcare 11.82%
4 Consumer Discretionary 11.25%
5 Industrials 9.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ESNT icon
726
Essent Group
ESNT
$6.33B
$2.56M 0.01%
56,154
+19,647
+54% +$900K
MED icon
727
Medifast
MED
$141M
$2.56M 0.01%
12,211
+5,026
+70% +$1.04M
LQDT icon
728
Liquidity Services
LQDT
$1.32B
$2.55M 0.01%
115,424
+46,367
+67% +$1.03M
USNA icon
729
Usana Health Sciences
USNA
$286M
$2.55M 0.01%
25,162
+8,092
+47% +$807K
NYT icon
730
New York Times
NYT
$10.2B
$2.54M 0.01%
52,547
+19,493
+59% +$963K
USPH icon
731
US Physical Therapy
USPH
$1.22B
$2.54M 0.01%
26,551
+11,929
+82% +$1.2M
APAM icon
732
Artisan Partners
APAM
$3.02B
$2.54M 0.01%
53,212
+19,807
+59% +$951K
BMI icon
733
Badger Meter
BMI
$4.03B
$2.54M 0.01%
23,794
+7,489
+46% +$789K
CORT icon
734
Corcept Therapeutics
CORT
$12B
$2.53M 0.01%
127,855
+48,808
+62% +$990K
MYRG icon
735
MYR Group
MYRG
$5.25B
$2.53M 0.01%
22,896
+7,350
+47% +$798K
TAP icon
736
Molson Coors Class B
TAP
$8.09B
$2.53M 0.01%
54,579
HII icon
737
Huntington Ingalls Industries
HII
$12.8B
$2.53M 0.01%
13,531
+192
+1% +$37.1K
AMED
738
DELISTED
Amedisys
AMED
$2.53M 0.01%
15,606
+6,234
+67% +$1M
PRG icon
739
PROG Holdings
PRG
$1.71B
$2.52M 0.01%
55,853
+18,818
+51% +$850K
TTC icon
740
Toro Company
TTC
$9.49B
$2.52M 0.01%
25,201
+9,358
+59% +$932K
DCI icon
741
Donaldson
DCI
$11.4B
$2.52M 0.01%
42,440
+14,588
+52% +$864K
NDSN icon
742
Nordson
NDSN
$17.3B
$2.51M 0.01%
9,847
+2,884
+41% +$738K
DAL icon
743
Delta Air Lines
DAL
$60.1B
$2.51M 0.01%
64,308
+14,933
+30% +$598K
RCL icon
744
Royal Caribbean
RCL
$85.6B
$2.51M 0.01%
32,681
-4,667
-12% -$379K
DGL
745
DELISTED
Invesco DB Gold Fund
DGL
$2.51M 0.01%
48,000
GOLF icon
746
Acushnet Holdings
GOLF
$5.45B
$2.5M 0.01%
47,196
+12,951
+38% +$681K
LMAT icon
747
LeMaitre Vascular
LMAT
$1.86B
$2.5M 0.01%
49,878
+21,435
+75% +$1.11M
IIIN icon
748
Insteel Industries
IIIN
$625M
$2.5M 0.01%
62,880
+14,865
+31% +$604K
XPEL icon
749
XPEL
XPEL
$1.38B
$2.5M 0.01%
36,612
+14,466
+65% +$1.04M
WIX icon
750
WIX.com
WIX
$2.52B
$2.5M 0.01%
15,821
-419
-3% -$72.7K

Similar funds

Aviva's Q4 2021 Portfolio in Review

As of Q4 2021, Aviva held 1,048 positions worth $23.9B, up 6.4% from $22.4B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Aviva withdrew a net $1.37B in Q4 2021, closing 27 positions and reducing 416 holdings. Its most notable exit was Coresite Realty Corporation, an estimated $33.7M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Aviva opened a new position in Rivian worth $4.38M.

  • Aviva's largest Q4 2021 buy was Rivian: 42,209 shares worth $4.38M.
  • Aviva added most to American Tower in Q4 2021, an estimated $114M increase.
  • Aviva's biggest Q4 2021 reduction was Stellantis, cutting an estimated $148M.
  • Aviva fully exited Coresite Realty Corporation in Q4 2021, selling an estimated $33.7M.
  • Aviva's ten largest holdings make up 24% of its $23.9B portfolio in Q4 2021.
  • Aviva opened 64 new positions and closed 27 in Q4 2021.
  • Aviva's portfolio value rose 6.4% quarter-over-quarter to $23.9B.

Based on Aviva's 13F filing for Q4 2021, filed 10 Feb 2022.